Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease.
Forte D, Barone M, Morsiani C, Simonetti G, Fabbri F, Bruno S, Bandini E, Sollazzo D, Collura S, Deregibus MC, Auteri G, Ottaviani E, Vianelli N, Camussi G, Franceschi C, Capri M, Palandri F, Cavo M, Catani L.
Forte D, et al. Among authors: palandri f.
J Exp Clin Cancer Res. 2021 Feb 1;40(1):49. doi: 10.1186/s13046-020-01776-8.
J Exp Clin Cancer Res. 2021.
PMID: 33522952
Free PMC article.